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ABSTRACT
Objectives: The clinical significance of nevus-associated 
melanoma compared with de novo melanomas remains 
controversial. It has been suggested that nevus-associated 
melanomas have a higher Breslow thickness and therefore 
worse prognosis. Over a 10-year period, this study evaluated 
the incidence of nevus-associated melanoma and its 
prognostic significance related to clinicopathologic features.
Methods: Cross-sectional study from 1995 through 2004 in 
a dermatopathology referral center. With available data, we 
evaluated sex, primary location, histologic subtype, Breslow 
thickness, Clark level, presence of ulceration, associated 
lesion, and histologic subtype of the associated lesion.
Results: Of 135,653 pathologic records from skin biopsy 
specimens over a 10-year period, 1,190 melanoma records 
were selected. Nevus-associated melanomas corresponded 
to 390 (32.8%) melanomas, with thin melanomas having 
a nevus 1.52 times the association observed with thick 
melanomas (>1.01 mm; 95% confidence interval, 1.16-1.99; 
P < .001). Superficial spreading melanoma was the most 
frequent, while no lentigo maligna melanoma was associated 
with nevi. The median Breslow thickness of nevus-associated 
melanomas was lower than that of de novo melanomas.
Conclusions: Nevus-associated melanomas, which 
represent one-third of the melanomas in southeast Brazil, 
are associated with intermittent sun exposure, superficial 
spreading melanomas, and lower Breslow thickness. This 
is one of the largest series describing nevus-associated 
melanomas in Latin America.
The global incidence of melanoma has risen in the past 
50 years, despite increasing awareness and public health 
campaigns.1,2  In the United States, the incidence rates have 
risen from 13 per 100,000 in 1990 to 21 per 100,000 in 
2006, corresponding to the sixth most frequently diagnosed 
cancer in men and seventh in women and one of the most 
frequently diagnosed cancers in youth.1 In southern Brazil, 
there has also been an increase in the relative incidence 
of melanoma, 38% among men and 11% among women, 
between 1979 and 1987.3 According to the National Institute 
of Cancer (Instituto Nacional do Câncer),4 3,170 new cases 
of melanoma in men and 2,060 in women were expected in 
Brazil in 2012, especially in the southern region of Brazil, 
where the population of European descent is greater. The lack 
of a centralized melanoma case registry and of mandatory 
disease notification may account, among other factors, for the 
nonconformity of national and international data.5
Among the melanoma risk factors described in the 
literature, the presence of multiple melanocytic nevi (>100 
nevi; relative risk [RR], 6.89; 95% confidence interval [CI], 
4.63-10.25) and atypical melanocytic nevi (RR, 6.36; 95% 
CI, 3.80-10.33)6,7 stands out, but the influence of preexisting 
pigmented lesions in melanoma genesis remains controversial.
Considering epidemiologic and histologic studies, 
melanoma seems to arise either in association with a 
preexisting nevus or de novo, without any associated lesion.8 
The described incidence of melanoma associated with a 
preexisting lesion may vary from 20% to 50%.9-16
The clinical significance of nevus-associated melanomas 
compared with de novo melanomas remains controversial. 
Some authors suggest that nevus-associated melanomas 
may have a higher Breslow thickness and therefore worse 
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prognosis.12 Other authors13,14 have obtained different 
results with a lower Breslow thickness for nevus-associated 
melanomas. There have been suggestions that the development 
of nevus-associated melanoma would increase the risk of 
having another nevus-associated melanoma by 9-fold.11
We aim to evaluate the incidence of nevus-associated 
melanoma and its association with clinical and pathologic 
features over a 10-year period.
Materials and Methods
This cross-sectional study was carried out in a 
dermatopathology center in São Paulo, Brazil. The study 
protocol was submitted and approved by research ethics 
committees of Universidade Federal de São Paulo/UNIFESP-
EPM (number 188.713, January 24, 2013).
All data available in pathologic records from skin 
biopsy specimens over a 10-year period (1995-2004) from 
a dermatopathology referral center were evaluated, and 
only melanoma records were included in this study. All 
melanoma cases were evaluated by a single experienced 
dermatopathologist (N.M.) using previously described 
morphologic features.17-19 The following parameters available 
in the melanoma pathologic records were considered for 
clinicopathologic correlation: sex, primary location, 
histologic subtype, Breslow thickness, Clark level, presence 
of ulceration, associated lesion, and histologic subtype of 
the associated lesion. Only data available in the pathologic 
records were included in the study. Regarding primary 
location, head and neck were grouped as “Head”; trunk and 
lumbar areas were grouped as “Trunk.” Histologic subtypes 
were classified as follows: superficial spreading melanoma 
(SSM), nodular melanoma (NM), lentigo maligna melanoma 
(LMM), acral lentiginous melanoma, and other (fusiform 
melanoma, desmoplastic melanoma, amelanotic melanoma, 
and melanoma metastasis). Since the distinction of melanoma 
cells and nevus cells, especially in nevoid melanomas, can be 
difficult and controversial, we chose not to include any of the 
nevoid melanoma cases in this study.20,21
Lesions located in the trunk and extremities were 
considered located in intermittent sun-exposed areas, while 
lesions in the head were considered located in chronic sun-
exposed areas. Genital and acral lesions were considered 
non–sun-exposed areas.
Statistical Analysis
For each analyzed variable, only data available 
were considered valid. Associated nevus was described 
with percentages and 95% CIs. To estimate the relation of 
associated nevus with selected risk factors, we calculated 
prevalence ratios (PRs) and 95% CIs, with associated nevus 
as a dependent variable and various exposure factors as 
independent variables.
Most independent variables were grouped into two or 
three categories. Variables selected in the univariate analysis 
at a .20 significance level were included in the multivariate 
analysis. PRs and their 95% CIs were estimated using a 
generalized linear model with binomial distribution and log 
link function.22
Statistical significance was assessed using the c2 test. 
The Mann-Whitney test was used for comparing the Breslow 
thicknesses of de novo and nevus melanomas. A two-sided 
P value of less than .05 was considered to indicate statistical 
significance. All analyses were performed using STATA/SE 
12.1 for Windows (StataCorp LP, College Station, TX).
Results
Of 135,653 pathologic records from skin biopsy specimens 
over a 10-year period (1995-2004), only the records with the 
diagnosis of melanoma were selected for the evaluation, 
totaling 1,190 melanoma records. Unfortunately, not all 
melanoma records presented all the parameters evaluated, 
with information missing in some cases. Therefore, only 
available data were considered valid for statistical analysis.
Melanomas were located mainly in trunk and extremities 
(424 [43.0%] of 985 and 305 [31.0%] of 985, respectively) 
❚Table 1❚. The most common histologic subtype was SSM 
(517 [62.3%] of 830) (Table 1). Most melanomas without 
any specified subtype corresponded to in situ melanomas 
(87.5%). Of all melanomas evaluated, 707 (61.1%) of 1,147 
were invasive melanomas, of which 446 (63.1%) of 707 were 
thin melanomas (Table 1). LMM was significantly associated 
with chronic sun-exposed areas (P < .001), while SSM and 
NM were related to intermittent sun-exposed areas. Almost 
three-fourths of the melanomas (729 [74.0%] of 985) were 
located in intermittent sun-exposed areas.
Of the general melanoma sample, 390 (32.8%) of 1,190 
(95% CI, 30.1%-35.5%) corresponded to nevus-associated 
melanomas. Regarding primary location, acral and head 
did not show any association with melanoma arising in a 
nevus (P = .706). Nevertheless, the trunk was significantly 
more likely to be associated with a nevus compared with 
the head (PR, 2.92; 95% CI, 2.15-3.97; P < .001; Table 1). 
No significant association was established between nevus-
associated melanoma and sex (P = .548).
When considering sun-exposed areas and nevus 
association, melanomas in chronic sun-exposed areas 
were associated with a lower risk of preexisting nevus 
compared with melanomas in intermittent sun-exposed 
areas (Table 1). Of all histologic subtypes, SSM represented 
most cases of nevus-associated melanoma (P < .001; 






Am J Clin Pathol  2014;142:485-491     487
487     DOI: 10.1309/AJCP4L5CJGKTJVDD     487
© American Society for Clinical Pathology
AJCP / Original Article
Table 1). After multivariate analysis, primary location and 
histologic subtype were the variables independently related 
to associated nevus (Table 1).
Of 390 nevus-associated melanomas, 243 (62.3%) were 
invasive melanomas ❚Image 1❚ and ❚Image 2❚. Applying the 
Mann-Whitney test, the median Breslow thickness for de 
novo melanomas (0.85; interquartile range, 0.50-1.75) was 
greater than that for nevus-associated melanomas (0.70; 
interquartile range, 0.45-1.08; P < .001) ❚Table 2❚.
Discussion
Because of Brazil’s ethnic diversity, the most common 
histologic subtype of melanomas varies according to the 
region in question, with SSM being the most frequent 
histologic subtype among the central-southern populations. 
The melanoma samples for this study were collected in São 
Paulo, located in southeast Brazil, where the white population 
is predominant, mainly due to European immigration. Our 
findings corroborate the international literature, in which 
SSM was the most common histologic subtype observed (517 
[62.3%] of 830; Table 1), and the primary location was the 
trunk, followed by extremities.1,5,23
LMM was the histologic subtype most related to chronic 
sun-exposed areas (P < .001), while SSM and NM were 
related to intermittent sun-exposed areas, corroborating the 
idea suggested by Whiteman et al24 that LMM is widely 
accepted to be caused by chronic sun exposure.25
The described nevus melanoma incidence may vary 
from 20% to 50% in the literature, considering clinical 
and epidemiologic studies. Regarding studies in which 
histologic evaluation of melanomas was conducted, benign 
nevus was found in association with 20.6% to 42% of 
melanomas, in agreement with the results obtained from 
this study (390 [32.8%] of 1,190 melanomas).12-14,26,27 The 
variables that were statistically significant in association 
with nevus-associated melanomas in univariate analysis 
were primary location, histologic subtype, and Breslow 
thickness, but after multivariate analysis, the only variables 
❚Table 1❚
Distribution of Melanoma Sample and Prevalence Ratio of Associated Lesions According to Clinical and Pathologic Variables
 Nevus Absent,  Nevus Present,   Crude PR Adjusted PR 
Variable No. (%) No. (%) P Value (95% CI) (95% CI)
Histologic subtype n = 589 n = 241 <.001 P < .001 P < .001
   SSM 302 (51.3) 215 (89.2)  3.02 (2.08-4.38) 2.65 (1.61-4.35)
   LMMa 124 (21.0) 0  1.00 1.00
   NM 113 (19.2) 21 (8.7)   
   ALM 33 (5.6) 3 (1.3)   
   Other 17 (2.9) 2 (0.8)   
Location  n = 668 n = 317 <.001 P < .001 P = .008
   Acral 49 (7.4) 10 (3.2)  1.00 1.00
   Head 165 (24.7) 29 (9.1)   
   Genitalb 1 (0.1) 2 (0.6)   
   Extremities 219 (32.8) 86 (27.1)  1.83 (1.30-2.57) 1.27 (0.83-1.96)
   Trunk 234 (35.0) 190 (60.0)  2.92 (2.15-3.97) 1.70 (1.15-2.51)
Solar exposure n = 668 n = 317 <.001 P < .001 
   No 50 (7.5) 12 (3.8)  1.00 
   Intermittent 453 (67.8) 276 (87.0)  1.95 (1.17-3.28) 
   Chronic 165 (24.7) 29 (9.2)  0.77 (0.42-1.42) 
Breslow thickness n = 776 n = 382 .210 P < .001 
   In situ melanomas  312 (40.2) 139 (36.4)   
   Invasive melanomas 464 (59.8) 243 (61.3)   
      Thin (≤1 mm)c 267 (58.6) 179 (74.6) <.001 1.52 (1.16-1.99)  
      Thick (>1 mm)c 189 (41.4) 61 (25.4) <.001 1.00 
         1.01-2.00 mm 98 (51.9) 49 (80.3)   
         2.01-4.00 mm 63 (33.3) 10 (16.4)   
         >4.00 mm 28 (14.8) 2 (3.3)   
Sex n = 789 n = 388 .502 P = .548 
   Female 417 (52.9) 197 (51.0)  1.00 
   Male 372 (47.1) 191 (49.0%)  1.06 (0.88-1.27) 
Clark leveld n = 760 n = 381 <.001 P = .002 
   I 315 (41.4) 140 (36.7)  1.75 (1.19-2.58) 
   II 146 (19.2) 79 (20.7)   
   III 194 (25.5) 134 (35.2)   
   IV 105 (13.8) 28 (7.3)  1.00 
ALM, acral lentiginous melanoma; CI, confidence interval; LMM, lentigo maligna melanoma; NM, nodular melanoma; Other, fusiform melanoma, amelanotic melanoma, 
desmoplastic melanoma, and metastasis of melanoma; PR, prevalence ratio; SSM, superficial spreading melanoma;.
a For PR value, LMM cases were not taken into account.
b For PR value, the only three cases of genital melanoma were not taken into account.
c Eleven melanomas did not present a measurable Breslow thickness (8 in general melanoma sample and 3 in nevus-associated melanoma sample).
d For PR value, Clark V cases were not taken into account.






488     Am J Clin Pathol  2014;142:485-491
488     DOI: 10.1309/AJCP4L5CJGKTJVDD    
© American Society for Clinical Pathology
Shitara et al / Nevus-Associated Melanomas
A B
C ❚Image 1❚ Nevus-associated melanoma. A, Melanoma 
associated with a nevus showing melanoma cells in the 
epidermis and associated dermal nevus (H&E, ×100). B, Same 
lesion showing positivity of melanoma cells and negativity of 
nevus cells (immunohistochemistry HMB-45, ×200). C, Same 
lesion showing intense positivity of intraepidermal melanoma 
cells and weakly positive nevus cells (Melan A, ×100).
BA
❚Image 2❚ Nevus-associated melanoma. A, Melanoma on the left side with large epithelioid atypical cells and nevus on the right 
side in dermis with small nonatypical cells (H&E, ×100). B, Detail of melanoma and nevus collision area (H&E, ×200).
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that remained independently associated with nevus-
associated melanoma were primary location (P = .008) and 
histologic subtype (P < .001; Table 1).
When considering the anatomic distribution of nevus-
associated melanomas, most melanomas were located on 
intermittent sun-exposed areas (trunk and extremities; Table 
1).13,28 The finding that the trunk is the most frequent primary 
location is in agreement with previous studies,12,13 being 2.92 
times more likely to be associated with a nevus-associated 
melanoma than other locations (95% CI, 2.15-3.97; P < .001; 
Table 1). What stands out is that acral and head did not show 
any association with nevi in the majority of melanomas (49 
[83.1%] of 59 and 165 [85.1%] of 194, respectively; Table 1). 
It has been suggested that this difference is unlikely to be due 
to the anatomic distribution of nevi, because nevus density, as 
a function of surface area, has been reported to be higher on 
the face than on the trunk.13
Of all histologic subtypes, the association of a nevus 
with SSM was 3.02 times the association observed with other 
histologic subtypes (95% CI, 2.08-4.38; P < .001; Table 1). 
It has been suggested that histologic subtype rather than 
thickness seems to be the primary factor, with SSM more 
likely to arise in a nevus than other types of melanoma.13,29 
Indeed, some authors found that NM was less related to 
nevus even after controlling for Breslow thickness.29 In 
addition, no LMM was related to nevus, despite being 
the melanoma subtype characterized by slow horizontal 
spreading along the basal cell layer,19 corroborating previous 
findings that it corresponds to the histologic subtype least 
likely to be associated with a nevus (Table 1).13,16,30 This 
may partially be due to the fact that LMM shows distinct 
clinical and epidemiologic characteristics and may arise from 
a different pathogenic pathway than does nevus-associated 
melanoma.13,31 LMM is more frequent in chronically sun-
damaged areas, while nevus-associated melanomas would 
be more frequent in intermittent sun-exposed areas.24,25 It 
has been suggested that there may be different pathways in 
melanoma genesis and that one determinant of melanoma 
development would be the propensity of the host to develop 
nevi.13,24,28,31-33 In the first pathway, melanocytes in nevus-
prone individuals would require modest amounts of sunlight 
only in the early stages of tumorigenesis, with host factors 
driving tumor progression thereafter, and in another pathway, 
melanocytes of people with a low propensity to develop 
nevi would require long-term accumulation of sun exposure 
for melanoma to develop. In the latter pathway, melanomas 
would increase with age and affect the chronically sun-
exposed skin of the head and neck, face, and distal and dorsal 
extremities, with the surrounding skin typically showing 
marked solar elastosis and typically not in association with 
a precursor melanocytic nevus or in patients with numerous 
melanocytic nevi. Microscopically, these melanomas show 
a radial growth phase comprising melanocytes arranged 
as solitary units with poor lateral circumscription. On the 
other hand, the nevus-related pathway would affect younger 
patients, decreasing with older age, arising primarily on the 
intermittently sun-exposed skin of the trunk and proximal 
extremities on individuals with multiple melanocytic nevi. 
Microscopically, these melanomas are composed of larger 
melanocytes that are arranged primarily in nests and display 
upward intraepidermal scatter in their radial growth phase. 
Our findings that nevus-associated melanomas were more 
frequent on the trunk and extremities, in intermittent sun-
exposed areas (P < .001), and of the SSM subtype, while most 
melanomas located on the head were not associated with a 
nevus and no LMM was found in association with a nevus, 
corroborate previous findings that there may be more than one 
pathway to melanoma genesis.
Roughly two-thirds of nevus-associated melanomas 
corresponded to invasive melanomas. Comparing thin 
and thick melanomas, thin melanomas were significantly 
associated with a nevus (PR, 1.52; 95% CI, 1.16-1.99; 
P < .001), in agreement with previous publications,14,34 
even though this parameter did not remain significant after 
multivariate analysis. The greater incidence of nevus-
associated melanoma in thin melanomas may be justified 
partially by the fact that melanoma progression destroys 
nevus cells, so early diagnosis may increase the chance of 
finding melanoma with associated nevus.30,35 Nevertheless, 
other authors did not find an association of an eclipsing of 
nevus cells by growing melanomas.36
The distribution of nevus subtypes observed in this study 
is pursuant to the findings of Marks et al,30 in that more 
than half of nevi associated with melanoma were common 
acquired nevi ❚Table 3❚. Nevertheless, we found a smaller 
percentage of atypical (or dysplastic) nevi. This difference 
may be explained by the lack of consensus regarding the 
diagnosis of atypical nevi in the literature.16,37-40
The prognostic significance of nevus-associated melanoma 
remains controversial in the literature. In a prospective study, 
Weatherhead et al12 suggested that nevus-associated melanoma 
had a higher Breslow thickness and therefore a worse prognosis 
compared with de novo melanomas. However, Garcia-Cruz et 
al35 could not demonstrate a significant difference between 
❚Table 2❚
Median Breslow Thickness Related to Presence or Absence of 
Associated Nevus
      Associated Nevus
Breslow Thickness, mm Yes No
Median 0.70 0.85
Interquartile range 0.45-1.08 0.50-1.75
Minimum-maximum 0.25-8.00 0.20-15.00 
No. of observations 240 456
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the prognosis of nevus-associated and de novo melanomas. 
Kaddu et al,14 after evaluation of 667 nevus-associated 
melanomas and 519 de novo control melanomas, found lower 
Breslow thickness and a 5-year survival rate of 93.5% for 
nevus-associated melanomas, even though the latter did not 
show statistical significance. Purdue et al13 also obtained a 
lower Breslow thickness for nevus-associated melanomas. 
The present study corroborates the findings of Kaddu et 
al14 and Purdue et al.13 The median Breslow thickness of 
nevus-associated melanomas was lower than that of de novo 
melanomas (Table 2), suggesting a more favorable prognosis 
based on the Breslow thickness of the primary melanoma,3,41,42 
although a 5-year survival assessment was not possible in this 
study due to the follow-up data being unavailable.
This is one of the largest series describing melanomas 
associated with nevus described in Latin America. Melanoma 
arising in a nevus represents one-third of the melanomas 
in southeast Brazil, being associated with thin, superficial 
spreading melanomas, located mainly on the trunk, 
corroborating the data in the international literature.13,14
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